Clinical trial · Interventional
Tahini and Dermatitis in Breast Cancer
The Effects of Tahini Consumption on Radiotherapy Induced Dermatitis in Breast Cancer - A Pilot Study
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This study aimed to investigate the effect of tahini on acute radiation dermatitis in breast cancer (BC) patients undergoing radiotherapy (RT). 50 eligible BC patients will randomly assign to consume tahini 48 gr per day during and 1 week after RT or with no intervention (control group). The radiation dermatitis will be assessed weekly according to the Radiation Therapy Oncology Group/ European Organization for Research and Treatment of Cancer (RTOG/EORTC) scales.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Breast Cancer | Malignant Breast Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| control | Other | — | UNRESOLVED |
| tahini | Dietary Supplement | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- ACTIVE_COMPARATOR
- label
- tahini
- description
- 48 gr per day
- interventionNames
- Dietary Supplement: tahini
- type
- PLACEBO_COMPARATOR
- label
- control
- description
- no intervention
- interventionNames
- Other: control
Primary outcomes (1)
- measure
- severity of dermatitis
- timeFrame
- 4 weeks
- description
- Change from Baseline severity at 4 weeks. The radiation dermatitis will be assessed according to the Radiation Therapy Oncology Group/ European Organization for Research and Treatment of Cancer (RTOG/EORTC) scales
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 18 Years
- Maximum age
- 70 Years
Show eligibility criteria text
Inclusion Criteria: * women with Brest Cancer undergoing adjutant Radiation therapy Exclusion Criteria: * previous history of RT, MRM, * concomitant presence of two or more malignant tumors * metastasis to other areas * allergy or intolerance to tahini * skin diseases and wounds * severe liver and renal disease * autoimmune diseases * pregnant and lactating women * those who treated with hypo fraction RT
References
Publications (0)
Data not yet available